FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3041133571> ?p ?o ?g. }

• W3041133571 abstract "Bladder cancer (BCa) is one of the important tumors that have been proven to be treatable with immunotherapy. This study aims to identify and validate a molecular prognostic index of BCa based on immunogenomic landscape analysis.The cancer genome atlas (TCGA) database and immunology database and analysis portal (ImmPort) database were used to identified differentially expressed immune-related genes (IRGs). Prognostic IRGs were screened and protein-protein interaction (PPI) network was constructed. Multivariate Cox analysis was performed to develop a molecular prognostic index of BCa. Internal and external validation were then performed in TCGA cohort and GEO cohort, respectively. Besides, we also explore the relationship between this index and clinical characteristics, immune cell infiltration and tumor microenvironment.A total of 61 prognostic IRGs were identified and a molecular prognostic index was developed. The top four hub genes included MMP9, IGF1, CXCL12 and PGF. The difference in overall survival between high-risk group and low-risk group was statistically significant. The area under curve of the receiver operating characteristic (ROC) curve was 0.757, suggesting the potential for this index. Besides, Internal validation using TCGA cohort and external validation using GEO cohort indicated that this index was of great performance in predicting outcome. T cells CD8, T cells CD4 memory activated, T cells follicular helper, macrophages M0, macrophages M2 and neutrophils were significantly associated with prognosis of BCa patients. Female, high grade, stage III&IV, N1-3 and T3-4 were associated significantly with higher risk score compared with male, low grade, stage I&II, N0 and T1-2, respectively. High risk score had a positive association with higher stromal score and ESTIMATE score while high risk score had a negative association with tumor purity.This study identified several prognostic immune-related genes of clinical value. Besides, we developed and validated a molecular index based on immunogenomic landscape analysis, which performed well in predicting prognosis of BCa. Further researches are needed to verify the effectiveness of this index and these vital genes." @default.
• W3041133571 created "2020-07-16" @default.
• W3041133571 creator A5023133109 @default.
• W3041133571 creator A5029586806 @default.
• W3041133571 creator A5043519261 @default.
• W3041133571 creator A5050239838 @default.
• W3041133571 creator A5051341113 @default.
• W3041133571 creator A5052330249 @default.
• W3041133571 creator A5052676364 @default.
• W3041133571 creator A5053905297 @default.
• W3041133571 creator A5061690935 @default.
• W3041133571 creator A5068584522 @default.
• W3041133571 creator A5077854326 @default.
• W3041133571 creator A5078627573 @default.
• W3041133571 creator A5083735109 @default.
• W3041133571 date "2020-07-11" @default.
• W3041133571 modified "2023-10-01" @default.
• W3041133571 title "Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis" @default.
• W3041133571 cites W1271572098 @default.
• W3041133571 cites W1966900148 @default.
• W3041133571 cites W2016712307 @default.
• W3041133571 cites W2057933055 @default.
• W3041133571 cites W2068108952 @default.
• W3041133571 cites W2072065123 @default.
• W3041133571 cites W2130430382 @default.
• W3041133571 cites W2133805572 @default.
• W3041133571 cites W2213276913 @default.
• W3041133571 cites W2411258991 @default.
• W3041133571 cites W2535963121 @default.
• W3041133571 cites W2549797787 @default.
• W3041133571 cites W2588769511 @default.
• W3041133571 cites W2620920447 @default.
• W3041133571 cites W2755503667 @default.
• W3041133571 cites W2761197355 @default.
• W3041133571 cites W2768426526 @default.
• W3041133571 cites W2771126532 @default.
• W3041133571 cites W2777002637 @default.
• W3041133571 cites W2806268524 @default.
• W3041133571 cites W2889066332 @default.
• W3041133571 cites W2904181886 @default.
• W3041133571 cites W2904672094 @default.
• W3041133571 cites W2932208596 @default.
• W3041133571 cites W2943881236 @default.
• W3041133571 cites W2946679053 @default.
• W3041133571 cites W2950727590 @default.
• W3041133571 cites W2965840381 @default.
• W3041133571 cites W2969380233 @default.
• W3041133571 cites W2972541602 @default.
• W3041133571 cites W2982139483 @default.
• W3041133571 cites W2982515585 @default.
• W3041133571 cites W3007526220 @default.
• W3041133571 cites W3015873274 @default.
• W3041133571 cites W3023397567 @default.
• W3041133571 cites W3024680380 @default.
• W3041133571 cites W4237269238 @default.
• W3041133571 doi "https://doi.org/10.1186/s12935-020-01343-3" @default.
• W3041133571 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7353795" @default.
• W3041133571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32675942" @default.
• W3041133571 hasPublicationYear "2020" @default.
• W3041133571 type Work @default.
• W3041133571 sameAs 3041133571 @default.
• W3041133571 citedByCount "15" @default.
• W3041133571 countsByYear W30411335712021 @default.
• W3041133571 countsByYear W30411335712022 @default.
• W3041133571 countsByYear W30411335712023 @default.
• W3041133571 crossrefType "journal-article" @default.
• W3041133571 hasAuthorship W3041133571A5023133109 @default.
• W3041133571 hasAuthorship W3041133571A5029586806 @default.
• W3041133571 hasAuthorship W3041133571A5043519261 @default.
• W3041133571 hasAuthorship W3041133571A5050239838 @default.
• W3041133571 hasAuthorship W3041133571A5051341113 @default.
• W3041133571 hasAuthorship W3041133571A5052330249 @default.
• W3041133571 hasAuthorship W3041133571A5052676364 @default.
• W3041133571 hasAuthorship W3041133571A5053905297 @default.
• W3041133571 hasAuthorship W3041133571A5061690935 @default.
• W3041133571 hasAuthorship W3041133571A5068584522 @default.
• W3041133571 hasAuthorship W3041133571A5077854326 @default.
• W3041133571 hasAuthorship W3041133571A5078627573 @default.
• W3041133571 hasAuthorship W3041133571A5083735109 @default.
• W3041133571 hasBestOaLocation W30411335711 @default.
• W3041133571 hasConcept C121608353 @default.
• W3041133571 hasConcept C126322002 @default.
• W3041133571 hasConcept C143998085 @default.
• W3041133571 hasConcept C2777701055 @default.
• W3041133571 hasConcept C2780352672 @default.
• W3041133571 hasConcept C50382708 @default.
• W3041133571 hasConcept C58471807 @default.
• W3041133571 hasConcept C71924100 @default.
• W3041133571 hasConcept C72563966 @default.
• W3041133571 hasConceptScore W3041133571C121608353 @default.
• W3041133571 hasConceptScore W3041133571C126322002 @default.
• W3041133571 hasConceptScore W3041133571C143998085 @default.
• W3041133571 hasConceptScore W3041133571C2777701055 @default.
• W3041133571 hasConceptScore W3041133571C2780352672 @default.
• W3041133571 hasConceptScore W3041133571C50382708 @default.
• W3041133571 hasConceptScore W3041133571C58471807 @default.
• W3041133571 hasConceptScore W3041133571C71924100 @default.
• W3041133571 hasConceptScore W3041133571C72563966 @default.
• W3041133571 hasIssue "1" @default.
• W3041133571 hasLocation W30411335711 @default.

• next